Brief: Huakang Biomedical Sees Loss Attributable Of About RMB 6.6 Mln For 9 Months
Oct 30 (Reuters) - Huakang Biomedical Holdings Co Ltd
8622.HK :
* SEES LOSS ATTRIBUTABLE OF APPROXIMATELY RMB 6.6 MILLION
FOR
NINE MONTHS
* EXPECTED RESULT DUE TO DECLINE IN SALES REVENUE IN MARKETS
WITHIN CHINA
Source text for Eikon: urn:newsml:reuters.com:*:nHKS2yc48V
Further company coverage: 8622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Joyzyme
See all newsChairman
Brief: Huakang Biomedical Trading In Co's Shares Halted
Brief: Huakang Biomedical Says Zhang Shuguang Resigns As Executive Director And Chairman
Brief: Huakang Biomedical Announces Zhang Yujing Appointed As Executive Director
Brief: Huakang Biomedical To Acquire 51% Interest In Hunan Keyue Biotechnology